Showing 1 - 14 results of 14 for search 'Shigehisa Kitano', query time: 0.04s
Refine Results
-
1
Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model by Norihiro Fujinami, Toshiaki Yoshikawa, Yu Sawada, Manami Shimomura, Tatsuaki Iwama, Shiori Sugai, Shigehisa Kitano, Yasushi Uemura, Tetsuya Nakatsura
Published 2016-03-01
Article -
2
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodes by Kazumi Okamura, Lifang Wang, Satoshi Nagayama, Makiko Yamashita, Tomohiro Tate, Saki Matsumoto, Manabu Takamatsu, Shigehisa Kitano, Kazuma Kiyotani, Yusuke Nakamura
Published 2024-12-01
Article -
3
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLC by Masayuki Shirasawa, Tatsuya Yoshida, Takaji Matsutani, Yuki Takeyasu, Naoko Goto, Shigehiro Yagishita, Shigehisa Kitano, Hiroaki Kuroda, Toyoaki Hida, Takayasu Kurata, Yuichiro Ohe
Published 2025-01-01
Article -
4
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment by Toru Hanamura, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, Chikako Honda, Sasagu Kurozumi, Naoki Niikura
Published 2023-01-01
Article -
5
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment by Toru Hanamura, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, Chikako Honda, Sasagu Kurozumi, Naoki Niikura
Published 2023-03-01
Article -
6
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer by Daiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, Makiko Yamashita, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Tamotsu Sugai, Wataru Obara
Published 2024-01-01
Article -
7
Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers by Yasutoshi Kuboki, Masafumi Ikeda, Shigehisa Kitano, Takafumi Koyama, Noboru Yamamoto, Yuki Yamaguchi, Yuki Nakagawa, Takaaki Ishida, Hidenori Mizugaki, Takatsugu Narikiyo, Ryoko Takubo, Chika Ogami, Mayuko Sekiya
Published 2024-07-01
Article -
8
Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer by Yukinori Ozaki, Junji Tsurutani, Toru Mukohara, Tsutomu Iwasa, Masato Takahashi, Yuko Tanabe, Hidetaka Kawabata, Norikazu Masuda, Manabu Futamura, Hironobu Minami, Koji Matsumoto, Kenichi Yoshimura, Shigehisa Kitano, Toshimi Takano
Published 2022-12-01
Article -
9
High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs by Hiroko Onagi, Yoshiya Horimoto, Asumi Sakaguchi, Daiki Ikarashi, Naotake Yanagisawa, Takayuki Nakayama, Tetsuya Nakatsura, Yumiko Ishizuka, Ritsuko Sasaki, Junichiro Watanabe, Mitsue Saito, Harumi Saeki, Takuo Hayashi, Atsushi Arakawa, Takashi Yao, Shigehisa Kitano
Published 2022-10-01
Article -
10
Prognostic Impact of Stimulator of Interferon Genes Expression in Triple Negative Breast Cancer by Tetsuyo Maeda, Makiko Ono, Tomo Osako, Tomohiro Chiba, Satoko Baba, Asumi Iesato, Yukinori Ozaki, Yuka Inoue, Natsue Uehiro, Yoko Takahashi, Takayuki Kobayashi, Takahiro Kogawa, Tomohiko Ohta, Shigehisa Kitano, Takayuki Ueno, Shinji Ohno
Published 2025-02-01
Article -
11
Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series by Aya Nishizawa, Koichi Takeda, Tetsuya Urasaki, Makiko Ono, Toshiaki Mochizuki, Taro Shiga, Motohiro Fujiwara, Takeshi Yuasa, Atsushi Murakami, Ryo Koike, Mayu Yunokawa, Hiroyuki Kanao, Keitaro Shimozaki, Daisuke Takahari, Takahiro Kogawa, Shunji Takahashi, Shigehisa Kitano
Published 2023-06-01
Article -
12
Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional... by Hiroaki Ikeda, Hiroshi Shiku, Shigehisa Kitano, Koji Kato, Shinichi Kageyama, Yoshihiro Miyahara, Mikiya Ishihara, Kazuto Takesako, Takashi Watanabe, Akihiko Matsumine, Makoto Endo, Tomomi Yamada, Satoshi Okumura, Naomi Kiyota, Kimikazu Yakushijin, Kohichi Takada, Shinichiro Kobayashi, Yasuhiro Nagata, Taizo Shiraishi, Keizo Horibe, Hiroshi Miwa
Published 2022-11-01
Article -
13
Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma by Yuki Katsuya, Yuki Katsuya, Shigehisa Kitano, Makiko Yamashita, Mayu Ouchi, Shigehiro Yagishita, Akinobu Hamada, Akinobu Hamada, Hiromi Nakamura, Fumie Hosoda, Tatsuhiro Shibata, Noriko Motoi, Noriko Motoi, Takayuki Nakayama, Takashi Seto, Shigeki Umemura, Yukio Hosomi, Miyako Satouchi, Makoto Nishio, Toshiyuki Kozuki, Toyoaki Hida, Toyoaki Hida, Yuichiro Ohe, Hidehito Horinouchi
Published 2023-01-01
Article -
14
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome by Takashi Kojima, Hiroaki Ikeda, Sachiko Okamoto, Junichi Mineno, Hiroshi Shiku, Shigehisa Kitano, Shinichi Kageyama, Yoshihiro Miyahara, Mikiya Ishihara, Daisuke Tomura, Ikuei Nukaya, Tetsuro Sasada, Noboru Yamamoto, Takashi Watanabe, Hideyuki Mishima, Alessandra Nardin, Evan Newell, Hidefumi Kato, Hiroyoshi Hattori, Takeru Funakoshi, Eiichi Sato, Hideto Chono, Muhammad Faris Kairi, Phuong Diem Hoang Nguyen, Yannick Simoni, Michael Fehlings
Published 2022-06-01
Article